253 related articles for article (PubMed ID: 35099270)
1. Gene-Edited Fluorescent and Mixed Cerebral Organoids.
Bachmann L; Gallego Villarejo L; Heinen N; Marks D; Peters M; Müller T
CRISPR J; 2022 Feb; 5(1):53-65. PubMed ID: 35099270
[TBL] [Abstract][Full Text] [Related]
2. Optical Genome Mapping Reveals Genomic Alterations upon Gene Editing in hiPSCs: Implications for Neural Tissue Differentiation and Brain Organoid Research.
Gallego Villarejo L; Gerding WM; Bachmann L; Hardt LHI; Bormann S; Nguyen HP; Müller T
Cells; 2024 Mar; 13(6):. PubMed ID: 38534351
[TBL] [Abstract][Full Text] [Related]
3. Generating and Utilizing Murine Cas9-Expressing Intestinal Organoids for Large-Scale Knockout Genetic Screening.
Kashfi H; Jinks N; Nateri AS
Methods Mol Biol; 2020; 2171():257-269. PubMed ID: 32705648
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model.
Cui S; Shin YJ; Fang X; Lee H; Eum SH; Ko EJ; Lim SW; Shin E; Lee KI; Lee JY; Lee CB; Bae SK; Yang CW; Chung BH
Transl Res; 2023 Aug; 258():35-46. PubMed ID: 36805562
[TBL] [Abstract][Full Text] [Related]
5. Generation of Knockout Gene-Edited Human Intestinal Organoids.
Rajendra C; Wald T; Barber K; Spence JR; Fattahi F; Klein OD
Methods Mol Biol; 2020; 2171():215-230. PubMed ID: 32705644
[TBL] [Abstract][Full Text] [Related]
6. Modeling of
Lim SW; Na D; Lee H; Fang X; Cui S; Shin YJ; Lee KI; Lee JY; Yang CW; Chung BH
Cells; 2023 Sep; 12(18):. PubMed ID: 37759541
[TBL] [Abstract][Full Text] [Related]
7. Human pluripotent stem cell-derived kidney organoids reveal tubular epithelial pathobiology of heterozygous HNF1B-associated dysplastic kidney malformations.
Bantounas I; Rooney KM; Lopes FM; Tengku F; Woods S; Zeef LAH; Lin IH; Kuba SY; Bates N; Hummelgaard S; Hillman KA; Cereghini S; Woolf AS; Kimber SJ
Stem Cell Reports; 2024 Jun; 19(6):859-876. PubMed ID: 38788724
[TBL] [Abstract][Full Text] [Related]
8. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids.
Liu X; Cheng Y; Abraham JM; Wang Z; Wang Z; Ke X; Yan R; Shin EJ; Ngamruengphong S; Khashab MA; Zhang G; McNamara G; Ewald AJ; Lin D; Liu Z; Meltzer SJ
Cancer Lett; 2018 Nov; 436():109-118. PubMed ID: 30144514
[TBL] [Abstract][Full Text] [Related]
9. Comparative Transcriptomic Analysis of Cerebral Organoids and Cortical Neuron Cultures Derived from Human Induced Pluripotent Stem Cells.
Kathuria A; Lopez-Lengowski K; Watmuff B; Karmacharya R
Stem Cells Dev; 2020 Nov; 29(21):1370-1381. PubMed ID: 32862797
[TBL] [Abstract][Full Text] [Related]
10. Convergence of human pluripotent stem cell, organoid, and genome editing technologies.
Wang L; Ye Z; Jang YY
Exp Biol Med (Maywood); 2021 Apr; 246(7):861-875. PubMed ID: 33467883
[TBL] [Abstract][Full Text] [Related]
11. Rapid target validation in a Cas9-inducible hiPSC derived kidney model.
Shamshirgaran Y; Jonebring A; Svensson A; Leefa I; Bohlooly-Y M; Firth M; Woollard KJ; Hofherr A; Rogers IM; Hicks R
Sci Rep; 2021 Aug; 11(1):16532. PubMed ID: 34400685
[TBL] [Abstract][Full Text] [Related]
12. Single-cell brain organoid screening identifies developmental defects in autism.
Li C; Fleck JS; Martins-Costa C; Burkard TR; Themann J; Stuempflen M; Peer AM; Vertesy Á; Littleboy JB; Esk C; Elling U; Kasprian G; Corsini NS; Treutlein B; Knoblich JA
Nature; 2023 Sep; 621(7978):373-380. PubMed ID: 37704762
[TBL] [Abstract][Full Text] [Related]
13. Modeling pancreatic pathophysiology using genome editing of adult stem cell-derived and induced pluripotent stem cell (iPSC)-derived organoids.
Hirshorn ST; Steele N; Zavros Y
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1142-G1150. PubMed ID: 33759566
[TBL] [Abstract][Full Text] [Related]
14. Modeling of Autism Using Organoid Technology.
Choi H; Song J; Park G; Kim J
Mol Neurobiol; 2017 Dec; 54(10):7789-7795. PubMed ID: 27844287
[TBL] [Abstract][Full Text] [Related]
15. Reaching into the toolbox: Stem cell models to study neuropsychiatric disorders.
Whiteley JT; Fernandes S; Sharma A; Mendes APD; Racha V; Benassi SK; Marchetto MC
Stem Cell Reports; 2022 Feb; 17(2):187-210. PubMed ID: 35063127
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9-Mediated Correction of
Lim SW; Fang X; Cui S; Lee H; Shin YJ; Ko EJ; Lee KI; Lee JY; Chung BH; Yang CW
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769335
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Characterization of Structural, Molecular, and Electrophysiological Phenotypes of Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoids, and Comparison with Fetal and Adult Gene Profiles.
Logan S; Arzua T; Yan Y; Jiang C; Liu X; Yu LK; Liu QS; Bai X
Cells; 2020 May; 9(5):. PubMed ID: 32456176
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic Mapping of Neural Diversity, Differentiation and Functional Trajectory in iPSC-Derived 3D Brain Organoid Models.
Kiaee K; Jodat YA; Bassous NJ; Matharu N; Shin SR
Cells; 2021 Dec; 10(12):. PubMed ID: 34943930
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic correction of hemophilia A using 2D endothelial cells and multicellular 3D organoids derived from CRISPR/Cas9-engineered patient iPSCs.
Son JS; Park CY; Lee G; Park JY; Kim HJ; Kim G; Chi KY; Woo DH; Han C; Kim SK; Park HJ; Kim DW; Kim JH
Biomaterials; 2022 Apr; 283():121429. PubMed ID: 35217482
[TBL] [Abstract][Full Text] [Related]
20. Genetic engineering in organoids.
Teriyapirom I; Batista-Rocha AS; Koo BK
J Mol Med (Berl); 2021 Apr; 99(4):555-568. PubMed ID: 33459801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
